436 related articles for article (PubMed ID: 34422802)
1. Role of Long Non-coding RNAs on Bladder Cancer.
Li HJ; Gong X; Li ZK; Qin W; He CX; Xing L; Zhou X; Zhao D; Cao HL
Front Cell Dev Biol; 2021; 9():672679. PubMed ID: 34422802
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and clinical studies.
Mirzaei S; Paskeh MDA; Hashemi F; Zabolian A; Hashemi M; Entezari M; Tabari T; Ashrafizadeh M; Raee P; Aghamiri S; Aref AR; Leong HC; Kumar AP; Samarghandian S; Zarrabi A; Hushmandi K
Life Sci; 2022 Jan; 288():119948. PubMed ID: 34520771
[TBL] [Abstract][Full Text] [Related]
3. Molecular landscape of LncRNAs in bladder cancer: From drug resistance to novel LncRNA-based therapeutic strategies.
Mehmandar-Oskuie A; Jahankhani K; Rostamlou A; Arabi S; Sadat Razavi Z; Mardi A
Biomed Pharmacother; 2023 Sep; 165():115242. PubMed ID: 37531786
[TBL] [Abstract][Full Text] [Related]
4. Tumor-derived urinary exosomal long non-coding RNAs as diagnostic biomarkers for bladder cancer.
Abbastabar M; Sarfi M; Golestani A; Karimi A; Pourmand G; Khalili E
EXCLI J; 2020; 19():301-310. PubMed ID: 32231490
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA BRAF-regulated lncRNA 1 promotes lymph node invasion, metastasis and proliferation, and predicts poor prognosis in breast cancer.
Jiang J; Shi SH; Li XJ; Sun L; Ge QD; Li C; Zhang W
Oncol Lett; 2018 Jun; 15(6):9543-9552. PubMed ID: 29805676
[TBL] [Abstract][Full Text] [Related]
6. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
7. New insights into long non-coding RNAs in breast cancer: Biological functions and therapeutic prospects.
Wang MQ; Zhu WJ; Gao P
Exp Mol Pathol; 2021 Jun; 120():104640. PubMed ID: 33878314
[TBL] [Abstract][Full Text] [Related]
8. LncRNA NRON promotes the proliferation, metastasis and EMT process in bladder cancer.
Xiong T; Huang C; Li J; Yu S; Chen F; Zhang Z; Zhuang C; Li Y; Zhuang C; Huang X; Ye J; Zhang F; Gui Y
J Cancer; 2020; 11(7):1751-1760. PubMed ID: 32194786
[No Abstract] [Full Text] [Related]
9. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
[TBL] [Abstract][Full Text] [Related]
10. Profiling of long non-coding RNAs identifies LINC00958 and LINC01296 as candidate oncogenes in bladder cancer.
Seitz AK; Christensen LL; Christensen E; Faarkrog K; Ostenfeld MS; Hedegaard J; Nordentoft I; Nielsen MM; Palmfeldt J; Thomson M; Jensen MT; Nawroth R; Maurer T; Ørntoft TF; Jensen JB; Damgaard CK; Dyrskjøt L
Sci Rep; 2017 Mar; 7(1):395. PubMed ID: 28341852
[TBL] [Abstract][Full Text] [Related]
11. Harnessing the potential of long non-coding RNAs in breast cancer: from etiology to treatment resistance and clinical applications.
Wang Y; Bu N; Luan XF; Song QQ; Ma BF; Hao W; Yan JJ; Wang L; Zheng XL; Maimaitiyiming Y
Front Oncol; 2024; 14():1337579. PubMed ID: 38505593
[TBL] [Abstract][Full Text] [Related]
12. Extracellular vesicle-transferred long noncoding RNAs in bladder cancer.
Xue M; Chen W; Li X
Clin Chim Acta; 2021 May; 516():34-45. PubMed ID: 33450212
[TBL] [Abstract][Full Text] [Related]
13. The Impact of lncRNA Dysregulation on Clinicopathology and Survival of Breast Cancer: A Systematic Review and Meta-analysis.
Tian T; Wang M; Lin S; Guo Y; Dai Z; Liu K; Yang P; Dai C; Zhu Y; Zheng Y; Xu P; Zhu W; Dai Z
Mol Ther Nucleic Acids; 2018 Sep; 12():359-369. PubMed ID: 30195774
[TBL] [Abstract][Full Text] [Related]
14. Effect of long noncoding RNA NONHSAT070806 on the apoptosis, proliferation, migration, invasion and tumorigenesis of bladder cancer.
Han D; Liu Y; Liu C; Jing C; Jia T; Wu Y; Si L; Yin Z; Yang G; Song T
Transl Androl Urol; 2022 Nov; 11(11):1544-1554. PubMed ID: 36507479
[TBL] [Abstract][Full Text] [Related]
15. Integrative Analysis of the Doxorubicin-Associated LncRNA-mRNA Network Identifies Chemoresistance-Associated lnc-TRDMT1-5 as a Biomarker of Breast Cancer Progression.
Chen Q; Yang H; Zhu X; Xiong S; Chi H; Xu W
Front Genet; 2020; 11():566. PubMed ID: 32547604
[TBL] [Abstract][Full Text] [Related]
16. The emerging roles of exosomal long non-coding RNAs in bladder cancer.
Liu Q
J Cell Mol Med; 2022 Feb; 26(4):966-976. PubMed ID: 34981655
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of lncRNA snoRNA host gene 6 regulates NUAK family SnF1-like kinase-1 expression by competitively binding microRNA-125b and interacting with Snail1/2 in bladder cancer.
Wang C; Tao W; Ni S; Chen Q
J Cell Biochem; 2019 Jan; 120(1):357-367. PubMed ID: 30168179
[TBL] [Abstract][Full Text] [Related]
18. The decalog of long non-coding RNA involvement in cancer diagnosis and monitoring.
Kunej T; Obsteter J; Pogacar Z; Horvat S; Calin GA
Crit Rev Clin Lab Sci; 2014 Dec; 51(6):344-57. PubMed ID: 25123609
[TBL] [Abstract][Full Text] [Related]
19. Urinary exosomal long non-coding RNAs as noninvasive biomarkers for diagnosis of bladder cancer by RNA sequencing.
Bian B; Li L; Ke X; Chen H; Liu Y; Zheng N; Zheng Y; Ma Y; Zhou Y; Yang J; Xiao L; Shen L
Front Oncol; 2022; 12():976329. PubMed ID: 36119544
[TBL] [Abstract][Full Text] [Related]
20. Tumor-Derived Exosomal Non-Coding RNAs: The Emerging Mechanisms and Potential Clinical Applications in Breast Cancer.
Yi Y; Wu M; Zeng H; Hu W; Zhao C; Xiong M; Lv W; Deng P; Zhang Q; Wu Y
Front Oncol; 2021; 11():738945. PubMed ID: 34707990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
